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Subcutaneous injections of hormone triiodothy-
ronine in rats resulted in peak blood levels at 24 hr with 
return to baseline by 96 hr. The injections stimulated a 
liver regeneration response that resembled in timing 
and in magnitude of DNA synthesis (peak, 24 hr) that 
induced by 40% hepatic resection. The principal pro-
liferation was of hepatocytes. Although there were 
some temporal differences from the gene expression of 
transforming growth factor-a, transforming growth 
factor-~I and c-Ha-ras that are known to follow partial 
hepatectomy, the overall profile of these changes was 
similar to those after partial resection. The effect was 
liver specific and could be reproduced three times with 
no diminution in response in the same animal with 
injections at 10-day intervals. No response was de-
tected in kidney or intestine. This effect in intact 
animals contrasted with the minimal ability of tri-
iodothyronine to stimulate hepatocytes in culture. 
However, when the culture medium was enriched with 
epidermal growth factor, there was a dose-related 
response to triiodothyronine. The totality of these 
experiments provides a preliminary basis for the cre-
ation with pharmacological techniques of an in vivo 
hyperplastic hepatic condition permissive of trans-
fection of new genes, as an alternative to partial 
hepatectomy. Although triiodothyronine was the test 
agent used, other hepatic growth factors singly or in 
combination could be candidates for this purpose. 
(HEPATOLOGY 1994;20:1237-1241.) 
The influence of T 3 on liver growth control has been 
demonstrated in rats by reduction in the normal hepatic 
regeneration response after thyroidectomy (1) and, 
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alternatively, by a proliferative response seen after 
subcutaneous T 3 injections in unaltered animals 
(2, 3). T 3 also has modest hepatotrophic effects (4) 
that are identified in the Eck fistula screen model 
by the stimulation of proliferation and the pre-
vention of hepatocyte atrophy (5). In this study, 
we further characterized the rat liver's response to 
T 3 including the mRNA to T 3 expression of the 
growth-associated genes TGF-a, TGF-f3 and c-
Ha-ras. Our immediate objective was to deter-
mine whether the changes in gene expression were 
comparable to those known to occur after partial 
hepatectomy (6, 7). For the transfection of new 
genes, a process that is known to be facilitated and 
prolonged under conditions of cellular proliferation (8), 
T 3 may be an acceptable substitute for partial hepa-
tectomy. 
MATERIALS AND METHODS 
Animals. Male Fischer F344 rats weighing between 180 and 
200 gm were obtained from Hilltop Lab Animals, Inc. (Scotts-
dale, PAl. The animals were housed in a temperature- and 
light-controlled room (21 0 to 220 C, light from 6 AM to 6 PM) and 
received food and water ad libitum. 
Materials. Type I collagenase (140 to 170 units/mg) was 
purchased from Worthington Diagnostic Systems (Freehold, 
NJ). Other materials and sources were formalin (Baxter 
Health Care Corp., McGaw Park, IL), Eagle's minimal es-
sential medium and fetal calf serum (GIBCO Laboratories, 
Grand Island, NY) , insulin, HEPES, pyruvic acid and T 3 
(Sigma Chemical Co., St. Louis, MO), EGF (Collaborative 
Research, Inc., Bedford, MA), [methyPH]thymidine (50 to 80 
Ci/mmol) (Du Pont-New England Nuclear, Boston, MA), 
35-mm tissue culture dishes (Corning, Inc., Corning, NY), 
gentamicin (Elins-Sinn, Inc., Cherry Hill, NJ), aqueous count-
ing solution (Amersham, Arlington Heights, IL) and mono-
clonal rabbit Elite anti-human AFP antibodies (Dako Corp., 
Carpinteria, CAl. 
Probes Used. cDNA fragments of human c-Ha-ras (cDNA 
Probe, Oncogene Science, Inc., Cambridge, MA), human 
qdc-~1 (9) (gift of Dr. A. Derynk, Genentech, Inc., San 
Francisco, CAl and rat TGF-a (10) (gift of Dr. David C. Lee, 
University of North Carolina, Chapel Hill, NC) were labeled 
with [32P]dCTP by means of random priming (Random Primer 
Labeling System; BRL, fndianap~lisI IN). An oligo for 28S 
cDNA (Oligo Probe; Oncor, Inc. Gaithersburg, MD) was 
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TABLE 1. Effects of different concentrations of T3 on 
hepatocyte proliferation in medium enriched with EGF 
and TGF-p 
o 
Medium additions 
(ng/ml) 
T:J (1 ng) 
EGF + T3 (0.01 ng) 
EGF + T3 (0.1 ng) 
EGF + T3 (1.0 ng) 
EGF + T3 (10 ng) 
EGF + T3 (1 ng) + TGF-[3 (1 ngl 
"Data expressed as mean ± S.D. 
[3H1Thymidine incorporation 
(cpm x 10-3/fLg proteins) 
102 ± 61" 
124 ± 70 
1,109 ± 98 
1,480 ± 129" 
1.920 ± 131b 
1,811 ± 191b 
304 ± 148 
bSignificantly different from the value obtained with EGF (10 
ng/mlJ alone in the culture medium: p < 0.0l. 
labeled with [32 PJdCTP by use of T4 kinase (end labeling 
system; BRL). 
In Vivo Experiments. Injections (200 j.l.g/100 gm rat bodywt) 
of T 3 were made subcutaneously on the backs of the animals 
in 0.1 ml of O.OlN NaOH-0.9% NaCI solution. Control rats 
were given similar injections of vehicle solution. 
DNA synthesis was determined in the livers, kidneys and 
small intestines of rats injected intraperitoneally with 50 !LCi 
[3HJthymidine/200 gm body wt 1 hr before being killed; the 
incorporation of [3Hlthymidine was then determined as 
described previously (11, 12). 
Proteins were determined by the method of Lowry et al. (13). 
Serum levels of T 3 were determined by means of RIA (Ciba 
Corning MAGIC T3 commercial kit; Ciba Corning Diagnostic 
Ltd., Halstead, Essex, UK). This procedure can measure T3 
concentrations to 8.0 nglml, with a minimum detectable 
concentration of less than 0.1 nglm!. The coefficient of 
variation of replicative sample assayed in our laboratory was 
6.53%. 
Tissue specimens from rat livers were fixed in 10% buffered 
formalin and embedded in paraffin; 4-!Lm sections were 
prepared and stained with hematoxylin and eosin. Monoclonal 
rabbit Elite anti-human AFP antibodies were used to examine 
AFP-positive cells. AFP immunostaining was performed as 
described by Palmer et a1. and Strenberger (14, 15), with the 
peroxidase avidin-biotin complex method (ABC; Vector Labo-
ratories, Burlingame, CAl and trypsin digestion control. The 
primary antibody dilution was 1: 250. As a positive control, 
anti-human AFP antibodies were tested in fetal rat liver 
sections. 
In Vitro Experiments. Hepatocytes from the livers of 
unaltered 7-wk-old male rats (180 to 200 gm) were isolated by 
means of a modification (16) of the in situ two-step collagenase 
perfusion technique (17, 18). Hepatocytes were dispersed and 
washed twice with cold Ca + + -free perfusion buffer and 
resuspended in serum-free Williams E medium supplemented 
with EGF on fibronectin-coated dishes. Viability was deter-
mined by means of trypan blue exclusion, and only prepara-
tions with viability greater than 90% at the outset were used. 
Cell number was determined with a hemocytometer. The cells 
were plated at a cell density of 3 x 105/35 mm in Corning 
tissue-culture dishes containing 1.5 ml medium and main-
tained at 37° C in a 5% CO2 atmosphere. Mter a 3-hr 
attachment period, the medium was aspirated, and 1.5 ml of 
Williams E medium with or without EGF, 10 nglml, was added. 
T 3 and TGF -/3, when used, were at the concentrations reported 
in Table 1. 
To determine in uitro DNA synthesis, we added 3 j.l.Ci 
[3HJthymidine to each well and maintained it from 48 to 72 hr 
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TABLE 2. DNA synthesis in kidney and small intestine from 
control (vehicle) and Ta-treated rats 
Organ 
Kidney 
Small intestine 
[3Hlthymidine incorporation 
(cpm/mg DNA x 10- 3 ) 
Vehicle (24 hr) 
2.6 ± 0.4" 
13.2 ± 2.2 
24 hr 
2.5 ± 0.4 
15.7 ± 0.8 
T3 
48 hr 
2.4 ± 0.3 
13.7 ± 2.5 
"Data expressed as mean ± S.D. 
of the culture period. When the cells were harvested, DNA 
content was determined by use of the microftuorometric 
method of Setaro and Morley (19), and DNA synthesis was 
measured as we have previously reported (16). 
Gene Expression Studies. Total cellular RNA from the rat 
livers was extracted by use ofRNAzol (Biotecx, Houston, TX). 
Total RNA (20 j.l.g) was subjected to electrophoresis in a 1 '7c 
agarose gel in 10 mmoliL Na3P04 with constant recirculation. 
The fractionated RNA was transferred to a Zitabind nylon 
membrane (Whatman, Maidstone, UK) overnight in 20 x 
standard saline citrate. Mter transfer, the blot was fixed with 
UV light (short wave, 254 nm). cDNA probes were labeled with 
32p with a random-primed labeling kit. Prehybridization was 
performed at 70° C from 30 min to 3 hr with Church buffer (1 % 
BSA, 7% SDS, 0.5 mol/L sodium phosphate, 1 mmol/L EDTA). 
For hybridization, 32P-labeled denatured probes in Church 
buffer were added at 70° C for hybridization (20). After 
hybridization, the membranes were washed twice in buffer A 
(1 % BSA, 5% SDS, 40 mmol/L sodium phosphate and 1 mmoliL 
EDTA) at 70° C for 20 min and then washed in buffer B (1% 
SDS, 40 mmollL sodium phosphate and 1 mmol/L EDTA) at 
70° C for 20 min (four times). 
The washed, air-dried membranes were subjected to auto-
radiography at - 70° C. To check for equivalent transfer of 
RNAs from agarose gel to membrane, we stained the gel with 
ethidium bromide after capillary transfer: Little RNA was 
found to remain in any lane. Before probe hybridization, the 
membranes were checked under UV light; similar amounts of 
RNA were found to have been transferred to each lane. This 
was always confirmed with separate probing with cDNA for 
28S RNA. The probes used were described. The products were 
subjected to electrophoresis on a 2% agarose gel with molecu-
lar-weight markers. The determination ofTGF-a, TGF-/3, and 
Ha-ras was chosen because the behavior of those genes has 
been completely established during the course of liver regen-
eration after partial hepatectomy (7, 9, 10). 
Statistical Analysis. Data are reported as mean ± S.D. The 
Student one-tailed t test was used for statistical analysis of the 
data. Any p value less than 0.05 was considered significant. 
RESULTS 
In Vivo Experiments. The serum concentration of T 3 
rose from control of 0.7 ± 0.3 ng/ml to 38.9 ± 5.3 ng/ml 
after 24 hr and had returned to control values by 4 days. 
Repeat injections 10 and 20 days later caused 24-hr peak 
levels of 28.2 ± 6.5 and 46.3 ± 7.4 ng/ml, respectively, 
with return to control by 96 hr. 
A peak response in DNA synthesis and mitoses was 
found at 24 hr followed by a lower second peak at 48 hr. 
Return to baseline required 96 hr (Fig. 1). When a 
second injection of T 3 was given to the same animals 10 
and 20 days after the first one, the same response was 
1 
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FIG. 1. Effect of a single injection of T 3 (200 1lg/100 gm body wt) on DNA synthesis and number of mitoses at different points after hormone 
injection. Significantly different from 0 time value: ' p < 0.001; *p < 0.01. 
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FIG. 2. Effect of repeated doses of T 3 on hepatic DNA synthesis. Significantly different from the value observed, each time, in the rats before 
T 3 injection: 'p < 0.01. 
obtained on all three occasions (Fig. 2). On histological 
and immunohistochemical examination, the mitotic 
figures were found predominantly in the AFP-negative 
hepatocytes. 
[3H]thymidine incorporation in the kidneys and small 
intestine was not affected by T 3 administration (Ta-
ble 2). 
In Vitro Experiments. T 3 alone had a minimal stim-
ulatory effect but caused a dose-related amplification of 
the DNA synthesis response to the primary hepatocyte 
mitogen EGF (Table 1). 
Gene Expression. T3 induced distinct peaks ofTGF-a 
expression, the principal one at 24 hr (Fig. 3) with a 
subsequent return almost to baseline. The second peak 
JE 2£ 
of increased expression appeared at 72 hr after T 3 
injection. The expression of c-Ha-ras was increased from 
24 hr to 120 hr (Fig. 4). The peak expression of TGF-Il 
was from 72 hr to 120 hr (Fig. 4). The mRNA of 288, a 
nongrowth gene, was used as an internal standard in all 
experiments to which other RNAs could be compared 
(Figs. 3 and 4). 
DISCUSSION 
The simplicity of T 3 injection for induction of hepatic 
proliferation in vivo suggests that this method might be 
used to facilitate gene incorporation into the hepatocyte 
DNA under experimental conditions. Because partial 
hepatectomy has been most commonly used in intact 
Q 
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FIG. 3. Northern-blot analysis of TGF -ot mRNA from livers of resting rats and from livers of rats at different points after a single injection 
ofTa (200 ~~1MM gm body wt). 
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FIG. 4. Northern-blot analysis of TGF -131 and c-Ha-ras mRNA levels from livers of resting rats and from livers of rats at different times after 
a single injection of T 3 (200 ~~1MM gm body wt). 
animals to provide the hyperplasia necessary for effi-
cient and prolonged gene transfection (8, 21-23), com-
parisons of the two techniques are in order. 
In most respects, the response to the T 3 doses used 
was similar to that following a moderate hepatic re-
section, with a peak response at 24 hr and return to 
baseline by 4 days. The secondary peak of DNA syn-
thesis, at 48 hr, was not attributable to delayed ab-
EEPATOLOGY Vol. 20, No.5, 1994 
sorption of the subcutaneously injected T 3' in view of the 
T 3 serum levels, which were maximal at day 1 and back 
to baseline by day 4 in association with proliferation of 
nonparenchymal cells, which are well known to have a 
delayed time of proliferation (24). A secondary small 
burst of DNA synthesis also has been seen after partial 
hepatectomy (25) and may represent in part a tempo-
rarily dissociated bile duct cell response (26-27). 
However, it was clear from the histopathological studies 
that the principal proliferation after T 3 was that of 
hepatocytes. Of considerable practical importance in the 
gene therapy context was the induction of undiminished 
proliferative response at lO-day intervals. 
The changes in liver mRNA of hepatic growth-
associated genes also were identical after T 3 injection to 
those known to occur after partial hepatectomy, in-
cluding the expression of TG F -a at 24 hr, TGF -13 at 72 
to 120 hr and c-Ha-ras from 24.to 120 hr. Minor 
deviations from the orderly sequence after partial 
hepatectomy included a delayed secondary peak of 
TGF -a mRNA at 72 hr and more prolonged expression 
of c-Ha-ras. 
These experiments support the feasibility of using a 
pharmacological approach as an alternative to hepatic 
resection for creation of a hyperplastic microenvi-
ronment conducive to gene insertion. For this purpose, 
T 3 is only one of several candidates - including hor-
mones, growth factors and some of the most potent 
T -cell-directed immunosuppressive agents (4). The need 
to screen for such substances for their hepatic growth 
effect in intact animals as opposed to tissue culture 
conditions was emphasized before (4) and exemplified in 
the in vitro experiments of this report, in which T 3 alone 
was almost inert. The dose-related effect of T 3 was 
detected in tissue culture only when it was added to a 
medium enriched with EGF. This finding is a simple 
demonstration of the complexity of the process of liver 
regeneration in vivo, which is a multifactorial phe-
nomenon that includes several growth factors, hor-
mones and cellular matrix components, along with 
complicated cell-to-cell interactions. 
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